Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Dis-Chem Pharmacies Yönetim
Yönetim kriter kontrolleri 4/4
Dis-Chem Pharmacies' CEO'su Rui Morais, Jul2023 tarihinde atandı, in görev süresi 1.25 yıldır. in toplam yıllık tazminatı ZAR 16.70M olup, şirket hissesi ve opsiyonları dahil olmak üzere 74.8% maaş ve 25.2% ikramiyelerden oluşmaktadır. şirketin hisselerinin 0.99% ine doğrudan sahiptir ve bu hisseler ZAR 321.61M değerindedir. Yönetim ekibinin ve yönetim kurulunun ortalama görev süresi sırasıyla 2.3 yıl ve 3.8 yıldır.
Anahtar bilgiler
Rui Morais
İcra Kurulu Başkanı
R16.7m
Toplam tazminat
CEO maaş yüzdesi | 74.8% |
CEO görev süresi | 1.3yrs |
CEO sahipliği | 1.0% |
Yönetim ortalama görev süresi | 2.3yrs |
Yönetim Kurulu ortalama görev süresi | 3.8yrs |
Son yönetim güncellemeleri
Recent updates
These 4 Measures Indicate That Dis-Chem Pharmacies (JSE:DCP) Is Using Debt Reasonably Well
Aug 21Shareholders Should Be Pleased With Dis-Chem Pharmacies Limited's (JSE:DCP) Price
Jun 06Dis-Chem Pharmacies (JSE:DCP) Will Be Hoping To Turn Its Returns On Capital Around
Apr 17Dis-Chem Pharmacies (JSE:DCP) Seems To Use Debt Quite Sensibly
Feb 26Dis-Chem Pharmacies (JSE:DCP) Might Be Having Difficulty Using Its Capital Effectively
Dec 30If EPS Growth Is Important To You, Dis-Chem Pharmacies (JSE:DCP) Presents An Opportunity
Sep 07Here's Why Dis-Chem Pharmacies (JSE:DCP) Can Manage Its Debt Responsibly
Aug 16Dis-Chem Pharmacies (JSE:DCP) Will Want To Turn Around Its Return Trends
Jul 31Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
May 09There Are Reasons To Feel Uneasy About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Mar 29Is Now The Time To Put Dis-Chem Pharmacies (JSE:DCP) On Your Watchlist?
Jan 14Returns On Capital At Dis-Chem Pharmacies (JSE:DCP) Paint A Concerning Picture
Nov 04Dis-Chem Pharmacies Limited (JSE:DCP) Shares Could Be 24% Below Their Intrinsic Value Estimate
Oct 04We Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Sep 01Some Investors May Be Worried About Dis-Chem Pharmacies' (JSE:DCP) Returns On Capital
Jul 04A Look At The Fair Value Of Dis-Chem Pharmacies Limited (JSE:DCP)
Jun 21Dis-Chem Pharmacies (JSE:DCP) Has A Pretty Healthy Balance Sheet
Jun 08The Dis-Chem Pharmacies Limited (JSE:DCP) Yearly Results Are Out And Analysts Have Published New Forecasts
May 25Is Dis-Chem Pharmacies (JSE:DCP) A Risky Investment?
Feb 23Dis-Chem Pharmacies Limited's (JSE:DCP) Price In Tune With Earnings
Feb 08I Ran A Stock Scan For Earnings Growth And Dis-Chem Pharmacies (JSE:DCP) Passed With Ease
Dec 13Dis-Chem Pharmacies' (JSE:DCP) Strong Earnings Are Of Good Quality
Nov 09CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Feb 29 2024 | R17m | R12m | R984m |
Nov 30 2023 | n/a | n/a | R942m |
Aug 31 2023 | n/a | n/a | R899m |
May 31 2023 | n/a | n/a | R949m |
Feb 28 2023 | R18m | R12m | R1b |
Nov 30 2022 | n/a | n/a | R1b |
Aug 31 2022 | n/a | n/a | R1b |
May 31 2022 | n/a | n/a | R946m |
Feb 28 2022 | R14m | R11m | R853m |
Nov 30 2021 | n/a | n/a | R815m |
Aug 31 2021 | n/a | n/a | R776m |
May 31 2021 | n/a | n/a | R722m |
Feb 28 2021 | R6m | R6m | R669m |
Nov 30 2020 | n/a | n/a | R655m |
Aug 31 2020 | n/a | n/a | R641m |
May 31 2020 | n/a | n/a | R620m |
Feb 29 2020 | R6m | R6m | R598m |
Nov 30 2019 | n/a | n/a | R573m |
Aug 31 2019 | n/a | n/a | R549m |
May 31 2019 | n/a | n/a | R634m |
Feb 28 2019 | R5m | R5m | R719m |
Nov 30 2018 | n/a | n/a | R718m |
Aug 31 2018 | n/a | n/a | R718m |
May 31 2018 | n/a | n/a | R701m |
Feb 28 2018 | R7m | R5m | R684m |
Tazminat ve Piyasa: Rui 'nin toplam tazminatı ($USD 960.63K ), ZA pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 1.38M ).
Tazminat ve Kazançlar: Rui 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.
CEO
Rui Morais (40 yo)
1.3yrs
Görev süresi
R16,702,000
Tazminat
Mr. Rui Manuel Morais, CA(SA) has been the Chief Executive Officer at Dis-Chem Pharmacies Limited since July 01, 2023 and its Executive Director since August 13, 2012. He served as Chief Financial Officer...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO & Executive Director | 1.3yrs | R16.70m | 0.99% ZAR 318.6m | |
CFO & Executive Director | 1.3yrs | R5.19m | Veri yok | |
Executive Director | 1.3yrs | R18.45m | Veri yok | |
Managing Director | 19.4yrs | R14.97m | Veri yok | |
Executive Director | 2.3yrs | R7.56m | 0.79% ZAR 252.8m | |
Executive Director | 2.3yrs | R7.58m | 4.65% ZAR 1.5b | |
Prescribed Officer | no data | R7.81m | Veri yok | |
Commercial Director | no data | R15.38m | 0.0045% ZAR 1.4m | |
Prescribed Officer | no data | R4.61m | 0.0012% ZAR 376.5k | |
Prescribed Officer | no data | R5.11m | Veri yok | |
Human Resources Director | no data | Veri yok | Veri yok | |
Company Secretary | 3.6yrs | Veri yok | Veri yok |
2.3yrs
Ortalama Görev Süresi
67yo
Ortalama Yaş
Deneyimli Yönetim: DCP 'un yönetim ekibi deneyimli olarak değerlendirilmektedir (ortalama görev süresi 2.3 yıldır).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
CEO & Executive Director | 12.2yrs | R16.70m | 0.99% ZAR 318.6m | |
CFO & Executive Director | 1.3yrs | R5.19m | Veri yok | |
Executive Director | 19.4yrs | R18.45m | Veri yok | |
Executive Director | 2.3yrs | R7.56m | 0.79% ZAR 252.8m | |
Executive Director | 2.3yrs | R7.58m | 4.65% ZAR 1.5b | |
Independent Non-Executive Chairman | 8yrs | R3.34m | 0.058% ZAR 18.8m | |
Independent Non-Executive Director | 8yrs | R967.00k | 0.0095% ZAR 3.0m | |
Independent Non-Executive Director | 8yrs | R691.00k | 0.019% ZAR 6.1m | |
Independent Non-Executive Director | 3.8yrs | R750.00k | Veri yok | |
Non-Independent Non Executive Director | 2.9yrs | R560.00k | Veri yok | |
Independent Non-Executive Director | 2.3yrs | R788.00k | Veri yok |
3.8yrs
Ortalama Görev Süresi
53.5yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: DCP 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.8 yıldır).